In the preceding paper, we described the isolation and structure eluci
dation of a series of even-numbered phenol- or pyrocatechol-derived I-
arylalkane-5-ones. To establish the assigned structures unambiguously
and to have larger quantities available for physiological testing, the
following compounds were prepared: in the alkylphenol series, 1-(4'-h
ydroxyphenyl)tetradecan-5-one (2a), 1-(4'-hydroxyphenyl)hexadecan-5-on
e (2b), and 1-(4'-hydroxyphenyl)octadecan-5-one (2c); in the alkyleate
chol series, 1-(3',4'-dihydroxyphenyl)decan-5-one (3a; not isolated as
a natural compound), 1-(3',4'-dihydroxyphenyl)dodecan-5-one (3b), 1-(
3',4'-dihydroxyphenyl)tetradecan-5-one (3c), 1-(3',4'-dihydroxyphenyl)
hexadecan-5-one (3d), 1-(3',4'-dihydroxyphenyl)octadecan-5-one (3e), a
nd 1-(3',4'-dihydroxyphenyl)icosan-5-one (3f); in the alkenylphenol se
ries, (Z)-1-(4'-hydroxyphenyl)octadec-13-en-5-one (4a) and (E)-1-(4'-h
ydroxyphenyl)octadec-13-en-5-one (4b); in the alkenylcatechol series,
(EE)-1-(3',4'-dihydroxyphenyl)deca-1,3-dien-5-one (1) and (Z)-1-(3',4'
-dihydroxyphenyl)octadec-13-en-5-one (5). All compounds proved to be i
dentical with the previously assigned structures. Compound 1 was synth
esized by regioselective aldol condensation of heptan-2-one with (E)-1
-(3',4'-dimethoxyphenyl)prop-2-enal (6d; Scheme 1), the phenols 2a-c a
nd the catechols 3a-f by addition of the corresponding alkyl Grignard
reagent to 5-(4'-methoxyphenyl)-or 5-(3',4'-dimethoxyphenyl)pentanal (
17c and 18c, resp.; Scheme 4), and the olefins 42, 4b and 5 from 17c o
r 18c via the 9-0 -silyl-protected 13-(4'-methoxyphenyl)- or 13-(3',4'
-dimethoxyphenyl)tridecanals (26 and 27, resp.) and Wittig olefination
as the key steps (Scheme 5).